On October 8, 2026, a narrative review titled "Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence" was published in the International Journal of Molecular Sciences. The publication compiles existing mechanistic, preclinical, and clinical evidence related to epitalon and epithalamin. This review is listed in the scientific literature under PubMed ID 42884164. Epithalon remains classified as an unapproved research compound, and no regulatory approval status is indicated by this publication. The review is categorized as a narrative review, meaning it synthesizes existing research rather than presenting new experimental data. No specific findings, conclusions, or outcomes from the review are detailed in the available event information. The publication appears in a peer reviewed molecular sciences journal, indicating it underwent editorial review prior to release. Readers interested in the broader context of epithalon research can consult the compound overview for additional background information on this peptide's research history and classification status.
Epitalon/Epithalamin Narrative Review Published in IJMS
See the full epithalon overview
Source: https://pubmed.ncbi.nlm.nih.gov/42884164/